Pharma Fallout: How Harrington v. Purdue Pharma Will Impact Bankruptcy Law

In the wake of the incredible harm caused by the opioid crisis, the outcome of the Purdue Pharma case argued in the United States Supreme Court garnered national attention. What impacts might this case have in bankruptcy court proceedings in the future? To unpack the details and gain understanding of the bankruptcy issues at play, Rocky Dhir talks with attorneys Elias Yazbeck and Michael Wombacher. They discuss the backstory of Purdue Pharma and the Sackler family, the journey of the case through the courts, and insights into the reasoning behind the Supreme Court’s decision, with a particular focus on the conflict over nonconsensual third-party releases.

Learn more about the case here: 23-124 Harrington v. Purdue Pharma L.P. (06/27/24)

Elias M. Yazbeck is an associate attorney in the Houston office of McGinnis Lochridge, LLP.

Michael Wombacher is an associate attorney at McDermott Will & Emery in Dallas, Texas.

Michael represented the Committee of Unsecured Creditors in the Robertshaw case:  Case number: 8:23-bk-80004 – Ebix, Inc. – Texas Northern Bankruptcy Court.